Compression Therapy Market to be Worth $5.88 Billion by 2030

Compression Therapy Market Size, Share, Forecast, & Trends Analysis by Product (Bandages, Stockings, Tapes, Pumps) Technique (Static, Dynamic) Condition (Varicose Vein, Lymphedema, Leg Ulcer) Distribution (E-commerce, Hospital) – Global Forecast to 2030

Meticulous Research—a leading global market research company, published a research report titled ‘Compression Therapy Market Size, Share, Forecast, & Trends Analysis by Product (Bandages, Stockings, Tapes, Pumps) Technique (Static, Dynamic) Condition (Varicose Vein, Lymphedema, Leg Ulcer) Distribution (E-commerce, Hospital) – Global Forecast to 2030.’

According to this latest publication from Meticulous Research, the compression therapy market is expected to reach $5.88 billion by 2030, at a CAGR of 3.8% from 2024 to 2030.The growth of this market is primarily driven by the rising global geriatric population, the increasing prevalence of chronic diseases, the growing number of sports and accident injuries, the growth in orthopedic procedures, the increasing cases of varicose veins and Deep Vein Thrombosis (DVT), the growing acceptance of compression therapy products as a preventive measure, and the minimal side effects and wide-ranging advantages of compression therapy. However, the lack of adherence to compression therapy among patients, the high costs of compression therapy garments, and the lack of awareness regarding compression therapy restrain the market’s growth.

Furthermore, emerging economies are expected to offer significant growth opportunities for the players operating in this market. However, the adoption of alternative technologies and an inadequate reimbursement structure for compression therapies are major challenges impacting market growth.

Key Players

The key players operating in the compression therapy market include 3M Company (U.S.), Essity Aktiebolag (publ) (Sweden), Bio Compression Systems, Inc. (U.S.), Arjo AB (Sweden), Convatec Inc. (U.S.), Cardinal Health, Inc. (U.S.), PAUL HARTMANN AG (Germany), Medline Industries, Inc. (U.S.), Julius Zorn, Inc. (U.S.), DJO, LLC (U.S.), Smith & Nephew plc (U.K.), medi GmbH & Co. KG (Germany), and SIGVARIS AG (Switzerland).

Compression Therapy Market: Future Outlook

The compression therapy market is segmented by Product [Bandages, Garments (Stockings {Class I, Class II, Class II}, Socks & Sleeves, Wraps & Tapes, and Other Garments), Intermittent/Sequential Pneumatic Compression Pumps (Non-segmented Pneumatic Compression Pumps, Segmented Pneumatic Compression Pumps), and Other Pressure Pumps], Technique [Static Compression Therapy and Dynamic Compression Therapy], Condition [Varicose Veins, Deep Vein Thrombosis, Lymphedema, Leg Ulcers, and Other Conditions], Distribution Channel [Hospitals & Clinics, Pharmacies & Retailers, E-commerce, and Other Distribution Channels], Facility (Healthcare Providers, Home-care Settings), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.

Among all products covered in this report, in 2024, the garments segment is expected to account for the largest share of the compression therapy market. The large market share of this segment is primarily attributed to the widespread adoption of compression therapy garments for edema and venous disorders. Additionally, some compression therapy garments are readily available off the shelf and are in high demand due to the increasing prevalence of conditions like varicose veins, chronic edema, and lymphedema among the geriatric population.

Among all techniques covered in this report, in 2024, the static compression therapy segment is expected to account for the larger share of the compression therapy market. The large market share of this segment is attributed to the widespread adoption of static compression therapy due to its benefits, including enhanced comfort during extended use, cost-effectiveness, user-friendly application, and reliable delivery of consistent pressure.

Among all conditions covered in this report, in 2024, the varicose veins segment is expected to account for the largest share of the compression therapy market. The large market share of this segment can be attributed to the increasing prevalence of varicose vein-related disorders among the elderly population, advancements in vein-specific compression therapeutic devices, and the growing number of obese individuals who are at a higher risk of developing varicose veins.

Among all distribution channels covered in this report, in 2024, the pharmacies & retailers segment is expected to account for the largest share of the compression therapy market. The large market share of this segment is attributed to the growing demand for compression therapy products and their wide accessibility through pharmacies that operate around the clock.

Among all facilities covered in this report, in 2024, the healthcare providers segment is expected to account for the larger share of the compression therapy market. The large market share of this segment is attributed to healthcare providers' increasing recommendation of using compression therapy solutions for people at risk of deep vein thrombosis and obesity, and the use of compression solutions in the management of chronic venous insufficiency.

Geographic Review

This research report analyzes major geographies and provides a comprehensive analysis of the compression therapy market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the compression therapy market. North America’s significant market share can be attributed to several factors, including the growing elderly population, high healthcare expenditures, the rising number of individuals with chronic conditions, and the presence of major market players in the region. According to the U.S. Census Bureau and Population Estimates and Projections, the geriatric population in the U.S. is expected to surpass 80 million by 2040, up from 56.1 million in 2020. This demographic shift is increasing the incidence of chronic diseases such as diabetes and vein-related disorders, driving the demand for home-care treatments and targeted therapies.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5640

Key Questions Answered in the Report:

Which are the high-growth market segments in terms of product, technique, condition, distribution channel, facility, and country/region?
What was the historical market size for compression therapy across the globe?
What are the market forecasts and estimates for the period 2024–2030?
What are the major drivers, restraints, opportunities, and challenges in the global compression therapy market?
Who are the major players in the global compression therapy market?
What is the competitive landscape like, and who are the market leaders in the global compression therapy market?
What are the recent developments in the compression therapy market?
What are the various strategies adopted by major players in the compression therapy market?
What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research